Congrats LibrarianMeg!! Keep going — you're doing incredible. 🎉

Clinical perspective on VENDOR RULES Read before posting ( Jan:

I have managed roughly 300 patients on GLP-1 therapy and this topic comes up frequently. What the data shows — and what I see in practice — is that proper titration prevents most adverse events.

For this specific question, I would recommend: reviewing the relevant clinical guidelines.

traveltech_sara said:

Keep going — you're doing incredible

I respect traveltech_sara perspective but I think this oversimplifies things a bit. Re: VENDOR RULES Read before — the effect size varies considerably by population.

I am not saying traveltech_sara wrong entirely — just that the picture is more nuanced than a blanket statement. The STEP data specifically shows dose-dependent variation.

Agreed. My doctor said the same thing about VENDOR RULES Read.

Want to share my personal experience related to VENDOR RULES Read before since I think it might help others in a similar situation.

I started my GLP-1 journey in October 2024 at 265 lbs with prediabetes and hypertension. My endocrinologist prescribed semaglutide 0.25mg to start.

Now, 16 months later: I am down 75 lbs, my labs have normalized, and I am off 2 of my 3 medications. The VENDOR RULES Read aspect specifically was something that made a big difference in my journey.

This community helped me every step of the way.